Literature DB >> 24021773

Preoperative cross-matching in major head and neck surgery: a study of a department's current practice and eligibility for electronic cross-matching.

Inas H Nasr1, Arathi Papineni McIntosh, Karim Hussain, Michael J Fardy.   

Abstract

OBJECTIVE: The maximum surgical blood ordering schedule (MSBOS) has reduced but not eliminated the over-ordering and wastage of blood products. Electronic cross-matching (ECM) may be a suitable alternative method to provide blood on demand in eligible cases. The purpose of this study was to assess the department's current blood ordering policy and to identify patients eligible for ECM. STUDY
DESIGN: This was a retrospective observational study of 88 consecutive maxillofacial surgical oncology patients.
RESULTS: A total of 383 units of blood were cross-matched, of which 43% were not transfused. Of these, 38% were reallocated and 5% discarded. Of all cross-matched blood, 82% was eligible for ECM; 18% was not eligible, 6% because of the presence of antibodies and 12% because of lack of a second historical sample.
CONCLUSIONS: ECM is recommended as a safe method for elective surgery. Blood can be provided on demand, reducing workload and costs for transfusion services and minimizing wastage.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24021773     DOI: 10.1016/j.oooo.2013.06.034

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  2 in total

1.  A Prospective Single Centre Study of Preoperative Blood Ordering Versus Actual Usage Among Patients Undergoing Elective Curative Oncological Resections in a Tertiary Care Hospital in India.

Authors:  Mohammed Basheeruddin Inamdar; Narendra Hulikal; Manilal Banoth; Venkatrami Reddy; Sreedhar Babu Kinnera Vijay; Hanumanthu Rao Mangu
Journal:  Indian J Surg Oncol       Date:  2021-05-29

2.  Benefits of VISION Max automated cross-matching in comparison with manual cross-matching: A multidimensional analysis.

Authors:  Hee-Jung Chung; Mina Hur; Sang Gyeu Choi; Hyun-Kyung Lee; Seungho Lee; Hanah Kim; Hee-Won Moon; Yeo-Min Yun
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.